The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded $3.4 million in grants to support high-impact projects for COVID-19 pandemic response, with funding authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act signed by President Donald Trump in March 2020.

The funding goes to four...

Biomanufacturing, COVID-19

Amid the coronavirus disease (COVID-19) crisis, BioFabConsulting would like to highlight the importance of adhering to the regulations to maintain patient safety. The FDA's mission is to protect and promote public health by helping safe and effective products reach the market, and the regulations are in place to uphold that mission.

A public health...

Additive Manufacturing, Biopharmaceutical, Digital Manufacturing, Education, Flexible Hybrid Electronics, Photonics, Process Intensification, Recycling, Robotics, Workforce

The Advanced Robotics for Manufacturing (ARM) Institute, through a partnership with its fellow Manufacturing USA® Institutes and led by Nextflex®, has been awarded funding from the Office of Naval Research for new manufacturing workforce education activities. The ARM Institute has partnered with Pittsburgh-based members, New Century Careers and...

External News

New Hampshire Union Leader
Biomanufacturing, Workforce

Manufacturing organs — the human variety, not the musical ones — sold Kalyan Vydiam on coming to work in the Millyard.

When the biomedical engineer explained his work at United Therapeutics to friends and family, some said, “‘OK, maybe they’re just building some small organs that are kind of like mimicking the lungs,’ but then we have to explain to...


This past January, the umpteenth version of the Segway Personal Transporter whisked attendees around in its white, egg-shaped seat at CES, the huge annual consumer electronics show in Las Vegas. Called the Segway S-Pod, it drew comparisons to the hover-chairs in Wall-E that shuttled around people so out of shape and blob-like, they’d forgotten how...

Our Network @ Work

FDA Stem Cells

There is growing awareness that the long-standing unmet need for specific counting of therapeutic tissue stem cells has been and continues to be a significant impediment to progress in stem cell therapy, gene and gene editing therapies (because targeting tissue stem cells is essential for durable one-time treatments), and drug development (because...